Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.

Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
复制标题

DOI:
10.1016/j.phrs.2008.03.013
复制
发表时间:
2008-05
影响因子:
9.3
通讯作者:
Swasti Tiwari;E. Blasi;J. Heyen;A. Mcharg;C. Ecelbarger
Swasti Tiwari;E. Blasi;J. Heyen;A. Mcharg;C. Ecelbarger
中科院分区:
医学1区
文献类型:
--
作者:
Swasti Tiwari;E. Blasi;J. Heyen;A. Mcharg;C. Ecelbarger

文献摘要

被引文献

相似文献

过氧化物酶体增殖物激活受体(PPAR-γ)激动剂可改善胰岛素敏感性,但与水肿相关。通过上皮钠通道(ENaC)和水通道蛋白-2(AQP-2)增加的远端小管钠和水重吸收已被认为起机制作用。为了确定这些蛋白质的分子调节,我们每天用溶剂、罗格列酮(RGZ,50 mg/kgbw)或PD 168(一种引起明显水肿的供试化合物,10 mg/kgbw)灌胃给药雄性Sprague-Dawley大鼠1、3或5天(n=6/治疗/次)。在第1天,RGZ显著降低尿钠排泄,PD 168的趋势较强(p值分别为0.047和0.053),表明早期钠潴留。RGZ或PD 168治疗12小时后血压降低。全肾匀浆(WKH)和膜富集部分(MF)的免疫印迹显示,两种药物在第1天时WKH中AQP-2的条带密度(29 kDa和糖基化条带)增加。然而,在第5天,29-kDa条带显著减少(溶剂的约30%)。RGZ在第3天增加了α-ENaC;然而,两种药物在第5天都降低了α-ENaC。相反,β-和γ-ENaC(85 kDa)在两种药物的作用下始终保持不变或降低。然而,在第3-5天,MF中γ-ENaC的70-kDa条带(活性条带)的密度被两种试剂增加(120-600%)。总体而言,这两种药物导致AQP-2和ENaC亚基带型的早期改变,其中许多被描述为活化变化。然而,随后AQP-2和α-ENaC的降低可能代表了重新建立钠和水平衡的尝试。
Peroxisome-proliferator-activated receptor (PPAR-γ) agonists improve insulin sensitivity, but are associated with edema. Increased distal tubule sodium and water reabsorption through the epithelial sodium channel (ENaC) and aquaporin-2 (AQP-2) have been suggested to play mechanistic roles. To determine the molecular regulation of these proteins, we treated male, Sprague–Dawley rats daily by gavage with either vehicle, rosiglitazone (RGZ, 50mg/kgbw), or PD168 (a test compound causing marked edema, 10mg/kgbw), for 1, 3, or 5 days (n=6/treatment/time). On day 1, urine sodium excretion was significantly reduced by RGZ with a strong trend for PD168 (p-values 0.047 and 0.053, respectively) indicating early sodium retention. Blood pressure was lowered by RGZ- or PD168 treatment by 12h. Immunoblotting of whole kidney homogenates (WKHs) and a membrane-enriched fraction (MF) revealed increased band densities for AQP-2 in WKH (29kDa and glycosylated bands) by both drugs at 1 day. However, at 5 days, the 29-kDa band was significantly decreased (∼30% of vehicle). α-ENaC was increased by RGZ at 3 days; however both agents decreased α-ENaC by 5 days. In contrast, β- and γ-ENaC (85kDa) were unchanged or decreased at all times by both agents. However, the 70-kDa band of γ-ENaC (active band) in MF was increased in density (120–600%) by both agents on days 3–5. Overall, both agents resulted in early alterations in banding patterns for AQP-2 and ENaC subunits, many of which are described as activating changes. However, later reduction in AQP-2 and α-ENaC may represent an attempt to re-establish sodium and water balance.